Elon Musk's Neuralink has received FDA clearance for its experimental Blindsight device, designed to restore vision by targeting the brain's visual cortex.

Elon Musk's Neuralink has received FDA approval for its vision-restoring implant, Blindsight, which aims to offer sight to people who are blind or have lost their vision. The device bypasses damaged optic nerves and stimulates the visual cortex,

Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.

The US FDA has awarded breakthrough device status to Neuralink's Blindsight, an experimental implant designed to restore vision. Developed by Elon Mus

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

Neuralink, a brain-computer interface company founded by Elon Musk, has announced a groundbreaking Blindsight implant that could restore vision to individuals who have lost both eyes. Musk shared this news on Wednesday,

Elon Musk's company, Neuralink, has developed a new brain implant called "Blindsight" that could potentially restore vision for some people with visual impairments.

The experimental implant received the FDA's "breakthrough device" designation, with founder Elon Musk highlighting its potential to restore vision, even for those blind from birth

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Blindsight is an innovative device designed to restore vision in people who have lost their sight, even in cases where both the eyes and optic nerve are damaged. Elon Musk highlighted on social media platform X that this technology could potentially enable individuals who have completely lost their sight,